- The World Health Organization (WHO) has prequalified Swiss Pharma Nigeria Limiteds sulphadoxine/pyrimethamine tablets
- Swiss Pharma Nigeria is recognized as the first local manufacturer in West and Central Africa to receive WHO prequalification for two products within 15 months
- The National Agency for Food and Drug Administration and Control (NAFDAC) announced this achievement as a result of successful collaboration with Swiss Pharma Nigeria Limited
WHO prequalifies Nigerian manufacturers for antimalarial tablet production
Photo credit: Alvarez/@officialnafdacSource: UGCNAFDAC: Prequalification as a result of successful collaboration”Swiss Pharma Nigeria is the first local manufacturer in West and Central Africa to achieve this milestone.”Being the first manufacturer to be recognized by the WHO as operating at an acceptable level of compliance to good manufacturing practice (GMP) requirements in West Africa in 2013, the manufacturer is now also the first manufacturer of finished pharmaceutical product to attain prequalification of 2 products in the West Africa and Central Africa Sub-region within the time space of 15months.NAFDAC intercepts 3 fuel tankers transport vegetable oil in Lagos